Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Corrado D.
        • Link M.S.
        • Calkins H.
        Arrhythmogenic right ventricular cardiomyopathy. Jarcho JA.
        N Engl J Med. 2017; 376: 61-72
        • Corrado D.
        • Wichter T.
        • Link M.S.
        • et al.
        Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement.
        Circulation. 2015; 132: 441-453
        • Cadrin-Tourigny J.
        • Bosman L.P.
        • Nozza A.
        • et al.
        A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
        Eur Heart J. 2019; (Available at:)
        • James C.A.
        • Bhonsale A.
        • Tichnell C.
        • et al.
        Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy–associated desmosomal mutation carriers.
        J Am Coll Cardiol. 2013; 62: 1290-1297
        • Gasperetti A.
        • Russo A.D.
        • Busana M.
        • et al.
        Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy.
        Heart Rhythm. 2020; 17: 1251-1259
        • Daimee U.A.
        • Assis F.R.
        • Murray B.
        • et al.
        Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: insights from the Johns Hopkins ARVC Program.
        Heart Rhythm. 2021; 18: 1369-1376
        • Della Bella P.
        • Baratto F.
        • Vergara P.
        • et al.
        Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? results from the multicenter randomized partita trial.
        Circulation. 2022; 145: 1829-1838
        • Tung R.
        • Xue Y.
        • Chen M.
        • et al.
        First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial.
        Circulation. 2022; 145: 1839-1849
        • Bhonsale A.
        • James C.A.
        • Tichnell C.
        • et al.
        Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
        J Am Coll Cardiol. 2011; 58: 1485-1496
        • Mukherjee R.K.
        • Whitaker J.
        • Williams S.E.
        • et al.
        Magnetic resonance imaging guidance for the optimization of ventricular tachycardia ablation.
        EP Europace. 2018; 20: 1721-1732
        • Esposito A.
        • Palmisano A.
        • Antunes S.
        • et al.
        Cardiac CT with delayed enhancement in the characterization of ventricular tachycardia structural substrate.
        JACC: Cardiovasc Imaging. 2016; 9: 822-832
        • Te Riele A.S.J.M.
        • James C.A.
        • Philips B.
        • et al.
        Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced: ARVD/C: the triangle of dysplasia displaced.
        J Cardiovasc Electrophysiol. 2013; 24: 1311-1320
        • Jiang R.
        • Nishimura T.
        • Beaser A.D.
        • et al.
        Spatial and transmural properties of the reentrant ventricular tachycardia circuit in arrhythmogenic right ventricular cardiomyopathy: simultaneous epicardial and endocardial recordings.
        Heart Rhythm. 2021; 18: 916-925
        • Gasperetti A.
        • Rossi V.A.
        • Chiodini A.
        • et al.
        Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria.
        Heart Rhythm. 2020; 18: 231-238
        • Philips B.
        • Madhavan S.
        • James C.A.
        • et al.
        Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear.
        Circ Arrhythm Electrophysiol. 2014; 7: 230-236
        • Pieroni M.
        • Dello Russo A.
        • Marzo F.
        • et al.
        High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy.
        J Am Coll Cardiol. 2009; 53: 681-689
        • Gökoğlan Y.
        • Mohanty S.
        • Gianni C.
        • et al.
        Scar homogenization versus limited-substrate ablation in patients with nonischemic cardiomyopathy and ventricular tachycardia.
        J Am Coll Cardiol. 2016; 68: 1990-1998
        • Mathew S.
        • Saguner A.M.
        • Schenker N.
        • et al.
        Catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: a sequential approach.
        J Acad Hosp Adm. 2019; 8: e010365
        • Subramanian M.
        • Ravilla V.V.
        • Yalagudri S.
        • et al.
        CT-guided percutaneous epicardial access for ventricular tachycardia ablation: a proof-of-concept study.
        Cardiovasc Electrophysiol. 2021; 32: 2665-2672